To qualify for Wegovy for CV risk reduction, you typically need: Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease), BMI 27 kg/m , and documentation of ongoing lifestyle modifications
Victoza (liraglutide) Approved uses: Adults and children over 10 with type 2 diabetes, and adults with type 2 diabetes and heart disease Drug type: Once-daily injection Doses: 0.6 mg (initial dose), 1.2 mg, and 1.8 mg Cost: Victoza is covered by most health plans, including Medicare and Medicaid
Moreover, because patients with T1D were excluded from studies looking at cardiovascular and renal outcomes with the use of GLP-1RA, it remains unknown whether those benefits observed in patients with T2D or obesity without T2D translate to the T1D population
The Tirzepitide arrived quickly & correctly
Topical Treatments Several over-the-counter options may help minimize hair loss: Minoxidil (Rogaine): FDA-approved for treating hair loss, available in 2% and 5% formulations